Shares of T2 Biosystems Inc. extended their losing streak to two days Wednesday despite the biotech clinching regulatory approval for a key diagnostic test. In a statement Tuesday, T2 Biosystems TTOO ...
T2 Biosystems (NASDAQ:TTOO) confirmed its plans to add detection of fungal pathogen Candida auris to its FDA-cleared and CE marked T2Candida Panel. A rare and often deadly fungal species is spreading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback